KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Deferred Tax Assets: 2012-2014

  • TherapeuticsMD's Current Deferred Tax Assets fell 10.83% to $152,478 in Q4 2014 from the same period last year, while for Dec 2014 it was $152,478, marking a year-over-year decrease of 10.83%. This contributed to the annual value of $152,478 for FY2014, which is 10.83% down from last year.
  • As of Q4 2014, TherapeuticsMD's Current Deferred Tax Assets stood at $152,478, which was down 10.83% from $170,996 recorded in Q4 2013.
  • Over the past 5 years, TherapeuticsMD's Current Deferred Tax Assets peaked at $170,996 during Q4 2013, and registered a low of $110,471 during Q4 2012.
  • Moreover, its 3-year median value for Current Deferred Tax Assets was $152,478 (2014), whereas its average is $144,648.
  • As far as peak fluctuations go, TherapeuticsMD's Current Deferred Tax Assets spiked by 54.79% in 2013, and later decreased by 10.83% in 2014.
  • Over the past 3 years, TherapeuticsMD's Current Deferred Tax Assets (Quarterly) stood at $110,471 in 2012, then surged by 54.79% to $170,996 in 2013, then declined by 10.83% to $152,478 in 2014.
  • Its last three reported values are $152,478 in Q4 2014, $170,996 for Q4 2013, and $110,471 during Q4 2012.